重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2014年
9期
1052-1054,1057
,共4页
耿卫朴%徐曼%张燕%陈瑜%黄文炼%王婷婷
耿衛樸%徐曼%張燕%陳瑜%黃文煉%王婷婷
경위박%서만%장연%진유%황문련%왕정정
宫颈肿瘤%T淋巴细胞%淋巴转移%PD-L2
宮頸腫瘤%T淋巴細胞%淋巴轉移%PD-L2
궁경종류%T림파세포%림파전이%PD-L2
uterine cervical neoplasms%T-lymphocytes%lymphatic metastasis%PD-L2
目的:检测负性共刺激分子PD-L2在人宫颈鳞状细胞癌的表达情况,分析其与患者临床病理特征的相关性,并观察重组人PD-L2蛋白对患者外周血T细胞凋亡的影响。方法采用免疫组织化学染色检测PD-L2蛋白在60例宫颈鳞状细胞癌患者癌组织中的表达,并统计分析PD-L2蛋白表达与宫颈鳞状细胞癌患者临床病理特征的相关性。将患者外周血T淋巴细胞分为空白对照组、PD-L2组和PD-L2+抗PD-1组单克隆抗体组,流式细胞术分析各组T细胞的凋亡率。结果宫颈鳞状细胞癌表达PD-L2的阳性率为53.3%(32/60)。PD-L2的表达与宫颈鳞状细胞癌的淋巴结转移相关(P<0.05)。PD-L2组宫颈鳞状细胞癌患者外周血活化CD4+ T和CD8+ T的凋亡率分别为17.0%和22.4%,明显高于空白对照组9.0%和16.2%;加入抗PD-1阻断PD-L2与T淋巴细胞、PD-1结合后,PD-L2+抗PD-1组CD4+ T和CD8+ T淋巴细胞凋亡率下降到11.1%和17.5%。结论宫颈鳞状细胞癌细胞异常表达PD-L2,且与肿瘤的淋巴结转移有关。PD-L2通过促进 T 细胞凋亡而削弱宫颈微环境的抗肿瘤免疫,并促进肿瘤的淋巴结转移。PD-L2/PD-1途径有可能成为宫颈鳞状细胞癌免疫治疗的靶点之一。
目的:檢測負性共刺激分子PD-L2在人宮頸鱗狀細胞癌的錶達情況,分析其與患者臨床病理特徵的相關性,併觀察重組人PD-L2蛋白對患者外週血T細胞凋亡的影響。方法採用免疫組織化學染色檢測PD-L2蛋白在60例宮頸鱗狀細胞癌患者癌組織中的錶達,併統計分析PD-L2蛋白錶達與宮頸鱗狀細胞癌患者臨床病理特徵的相關性。將患者外週血T淋巴細胞分為空白對照組、PD-L2組和PD-L2+抗PD-1組單剋隆抗體組,流式細胞術分析各組T細胞的凋亡率。結果宮頸鱗狀細胞癌錶達PD-L2的暘性率為53.3%(32/60)。PD-L2的錶達與宮頸鱗狀細胞癌的淋巴結轉移相關(P<0.05)。PD-L2組宮頸鱗狀細胞癌患者外週血活化CD4+ T和CD8+ T的凋亡率分彆為17.0%和22.4%,明顯高于空白對照組9.0%和16.2%;加入抗PD-1阻斷PD-L2與T淋巴細胞、PD-1結閤後,PD-L2+抗PD-1組CD4+ T和CD8+ T淋巴細胞凋亡率下降到11.1%和17.5%。結論宮頸鱗狀細胞癌細胞異常錶達PD-L2,且與腫瘤的淋巴結轉移有關。PD-L2通過促進 T 細胞凋亡而削弱宮頸微環境的抗腫瘤免疫,併促進腫瘤的淋巴結轉移。PD-L2/PD-1途徑有可能成為宮頸鱗狀細胞癌免疫治療的靶點之一。
목적:검측부성공자격분자PD-L2재인궁경린상세포암적표체정황,분석기여환자림상병리특정적상관성,병관찰중조인PD-L2단백대환자외주혈T세포조망적영향。방법채용면역조직화학염색검측PD-L2단백재60례궁경린상세포암환자암조직중적표체,병통계분석PD-L2단백표체여궁경린상세포암환자림상병리특정적상관성。장환자외주혈T림파세포분위공백대조조、PD-L2조화PD-L2+항PD-1조단극륭항체조,류식세포술분석각조T세포적조망솔。결과궁경린상세포암표체PD-L2적양성솔위53.3%(32/60)。PD-L2적표체여궁경린상세포암적림파결전이상관(P<0.05)。PD-L2조궁경린상세포암환자외주혈활화CD4+ T화CD8+ T적조망솔분별위17.0%화22.4%,명현고우공백대조조9.0%화16.2%;가입항PD-1조단PD-L2여T림파세포、PD-1결합후,PD-L2+항PD-1조CD4+ T화CD8+ T림파세포조망솔하강도11.1%화17.5%。결론궁경린상세포암세포이상표체PD-L2,차여종류적림파결전이유관。PD-L2통과촉진 T 세포조망이삭약궁경미배경적항종류면역,병촉진종류적림파결전이。PD-L2/PD-1도경유가능성위궁경린상세포암면역치료적파점지일。
Objective To determine PD-L2 expression in human cervical squamous cell carcinomas and analyze its association with the clinical and pathologic characteristics of these cases ;observe the role of recombinant PD-L2 protein on apoptosis of active peripheral blood T lymphocytes of cervical carcinoma patients .Methods PD-L2 expression in cervical squamous cell carcinomas was determined by immunohistochemistry staining ,and the association between PD-L2 expression with the clinical and pathologic characteristics of these cases was analyzed .In vitro ,the peripheral blood T lymphocytes of cervical carcinoma patients were divided into blank group ,PD-L2 group and PD-L2+anti-PD-1 group respectively .After these active T cells were cultured 72 h ,their apop-totic rates were detected by flow cytometry .Results PD-L2 expressed in 53 .3% (32/60)cervical squamous cell carcinomas ,and it′s expression associated with lymph node metastasis of these cases (P< 0 .05) .In vitro ,PD-L2 promoted apoptosis of CD4+ T and CD8+ T lymphocytes ,the apoptotic rates were 17 .0% and 22 .4% respectively ,which were higher than 9 .0% and 16 .2% of blank group;however ,the apoptotic rates dropped to 11 .1% and 17 .5% in PD-L2+anti-PD-1 group .Conclusion PD-L2 aberrantly ex-presses in cervical squamous cell carcinomas and is associated with their lymph node metastasis .PD-L2 promotes apoptosis of T lymphocytes and depresses the anti-tumor immunity of cervical microenvironment ,and promotes lymph node metastasis of these cancers .PD-L2/PD-1 pathway may be a potential immunotherapy target of cervical squamous cell carcinomas .